Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
-
661
Microarray analysis from GEO database showed TNFAIP9 was enhanced in CKD patients and mice.
Published 2025Subjects: -
662
-
663
-
664
-
665
-
666
-
667
-
668
-
669
-
670
-
671
-
672
-
673
-
674
-
675
-
676
-
677
PAS staining of intestinal sections from <i>T. spiralis</i>-infected mice pretreated with DAS and Y27632.
Published 2025“…<b>B</b>: Number of intestinal goblet cells (n = 3). <b>C</b>: Muc2 mRNA transcription level (n = 3). <b>D</b>: Muc5ac mRNA transcription level (n = 3). …”
-
678
CO<sub>2</sub> Reduction Characteristics at Pt<sub>0.5</sub>Ru<sub>0.5</sub>/C Cathode of H<sub>2</sub>-CO<sub>2</sub> Polymer Electrolyte Fuel Cell (Supporting Information)
Published 2025“…In this study, we investigated the CO<sub>2</sub> reduction using a Pt<sub>0.5</sub>Ru<sub>0.5</sub>/C electrocatalyst in order to realize a continuous CH<sub>4</sub> production. …”
-
679
Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV‑2 Main Protease
Published 2023“…Drugs that target the main protease (M<sup>pro</sup>) of SARS-CoV-2 are effective therapeutics that have entered clinical use. …”
-
680
Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV‑2 Main Protease
Published 2023“…Drugs that target the main protease (M<sup>pro</sup>) of SARS-CoV-2 are effective therapeutics that have entered clinical use. …”